HomeAKRO • NASDAQ
Akero Therapeutics Inc
$49.63
Jan 27, 3:25:12 PM GMT-5 · USD · NASDAQ · Disclaimer
Top gainerStockUS listed securityUS headquartered
Previous close
$26.18
Day range
$48.47 - $58.40
Year range
$15.32 - $58.40
Market cap
3.46B USD
Avg Volume
797.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
Operating expense
81.70M75.27%
Net income
-72.70M-83.33%
Net profit margin
Earnings per share
-1.05-47.89%
EBITDA
-81.70M-75.29%
Effective tax rate
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
717.25M29.30%
Total assets
817.55M28.68%
Total liabilities
79.22M51.78%
Total equity
738.32M
Shares outstanding
69.80M
Price to book
2.47
Return on assets
-24.28%
Return on capital
-25.40%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
-72.70M-83.33%
Cash from operations
-70.42M-41.64%
Cash from investing
73.07M158.13%
Cash from financing
3.07M280.52%
Net change in cash
5.71M103.27%
Free cash flow
-45.93M-25.63%
About
Founded
2017
Employees
60
Search
Clear search
Close search
Google apps
Main menu